Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Clinical trial NCT03303599 · COMPLETED
Trial details
- NCT number
- NCT03303599
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-13
- Primary completion
- 2020-01-24
- Enrollment
- 2118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.